Associazione per promuovere la bioindustria innovativa
Aziende partecipanti
Marche Biotech
A+ a-
Angelini

MARKET SECTOR: Pharmaceutical

 

COMPANY DESCRIPTION

Angelini is a private healthcare company with business in consumer and pharmaceutical markets established in Italy in the early 20th century. It is an integrated company which researches, develops, manufactures and markets drugs, medical devices, food supplements and active ingredients, covering directly 13 European territories. Angelini distributes its products worldwide in 60 territories through a network of business partners.

 

ANGELINI PIPELINE MAIN PROJECTS

Clinical Stage:

•Bindarit: a unique MCP-1/CCL2 production inhibitor. Indication: Diabetic Nephropathy and Restenosis. Phase IIB.

•Prulifloxacin: an antibacterial fluoroquinolone. New Indications in Respiratory & Urinary Tract Infections. Phase III.

•Trazodone: a SARI Antidepressant. Improved "Once a Day" formulation by Labopharm Contramid® Technology. Pre-Registration.

Preclinical Stage:

•Polglumyt®: Bio-Polymers for drug delivery

•MCP-1/CCL2 & selected cytokines productions inhibitors;

•AF3485: mPGES-1 inhibitors in Inflammatory Pain & Oncology

•AF3473: 5-HT4 antagonists in Neuropathic Pain.

•Proprietary Compounds: 5-HT2A antagonists; PPARγ modulators.

 

 

 

next >>